Seattle, WA, United States of America

John Robert Gillespie


Average Co-Inventor Count = 10.4

ph-index = 3

Forward Citations = 243(Granted Patents)


Location History:

  • Round Rock, TX (US) (1998 - 2000)
  • Seattle, WA (US) (2016 - 2021)

Company Filing History:


Years Active: 1998-2021

Loading Chart...
6 patents (USPTO):Explore Patents

Title: John Robert Gillespie: Innovator in Biochemical Research

Introduction

John Robert Gillespie is a notable inventor based in Seattle, WA, with a significant contribution to the field of biochemical research. He holds a total of six patents, showcasing his innovative approach to solving complex problems in medicine and biology.

Latest Patents

Gillespie's latest patents include "Specific inhibitors of methionyl-tRNA synthetase," which focuses on compositions useful in the inhibition of MetRS and methods for treating diseases that benefit from this inhibition. Another significant patent is "Compounds for treatment of trypanosomes and neurological pathogens and uses thereof," which relates to novel compounds that effectively cross the blood-brain barrier and inhibit neurological pathogens such as trypanosomes. This invention also addresses the treatment of disorders associated with these pathogens.

Career Highlights

Throughout his career, Gillespie has made substantial contributions to the scientific community, particularly in the development of therapeutic compounds. His work has implications for treating various diseases, highlighting his role as a key innovator in the field.

Collaborations

Gillespie has collaborated with notable professionals, including Rand W Mueller and Robert J Pizzuti, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

John Robert Gillespie's innovative work in biochemical research and his six patents reflect his dedication to advancing medical science. His contributions continue to influence the development of treatments for complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…